CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.1.1 Base case scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.1.1 Top investment pockets
3.1.2 Top winning strategies
3.2 Porters five forces analysis
3.2.1 Bargaining power of suppliers
3.2.2 Bargaining power of buyers
3.2.3 Threats from new entrants
3.2.4 Competitive rivalry
3.2.5 Threats from substitute products
3.3 Market share analysis, 2014
3.4 Drivers
3.4.1 Rising prevalence of chronic diseases and related surgeries
3.4.2 Rising geriatric and obese population
3.4.3 Technological advancements
3.4.4 Aggressive market strategies adopted by top players
3.5 Restraints
3.5.1 High cost associated with surgeries
3.5.2 Strict regulation and reimbursement issues
3.5.3 Lack of awareness in LAMEA region
3.5.4 Increasing popularity of minimally invasive surgeries
3.6 Opportunities
3.6.1 Availability of multifunctional products
3.6.2 Rapidly changing healthcare infrastructure in developing countries
CHAPTER 4 WORLD BIOSURGERY MARKET, BY PRODUCT, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Anti-adhesive agents
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Hemostatic agents
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Surgical sealing agents
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Natural/biologics surgical sealant
4.4.4.1 Market size and forecast
4.4.5 Synthetic surgical sealants
4.4.5.1 Market size and forecast
4.5 Bone Graft Substitutes
4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast
4.5.4 Cell based matrices
4.5.4.1 MArket size and forecast
4.5.5 Bone morphogenetic proteins
4.5.5.1 MArket size and forecast
4.5.6 Demineralised bone matrix
4.5.6.1 MArket size and forecast
4.5.7 Synthetic grafts extenders
4.5.7.1 MArket size and forecast
4.6 Soft tissue management (mesh/patch)
4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast
4.6.4 Biologics/natural soft tissue management (mesh/patch)
4.6.4.1 MArket size and forecast
4.6.5 Synthetic soft tissue management (mesh/patch)
4.6.5.1 MArket size and forecast
CHAPTER 5 WORLD BIOSURGERY MARKET, BY APPLICATION, 2014-2022 OVERVIEW
5.1.1 Market size and forecast
5.2 Cardiovascular and thoracic surgery
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Neuro and Spine surgery
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Orthopaedic surgery
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.5 General surgery
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.6 Others
5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
CHAPTER 6 WORLD BIOSURGERY MARKET, BY SOURCE, 2014-2022
6.1 Overview
6.1.1 Market size and forecast
6.2 Biologics Products
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Synthetics products
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
CHAPTER 7 WORLD BIOSURGERY MARKET, BY GEOGRAPHY, 2014-2022
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Europe
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Asia Pacific
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
7.5 LAMEA
7.5.1 Key market trends
7.5.2 Key growth factors and opportunities
7.5.3 Market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Business performance
8.1.4 Key strategic moves and developments
8.1.5 SWOT analysis
8.2 Baxter International Inc.
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Business performance
8.2.4 Key strategic moves and developments
8.2.5 SWOT analysis
8.3 C. R. Bard Inc.
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Key strategic moves and developments
8.3.4 Business performance
8.3.5 SWOT analysis
8.4 Johnson and Johnson
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Business performance
8.4.4 Key strategic moves and developments
8.4.5 SWOT analysis
8.5 Stryker Corporation
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Business performance
8.5.4 Key strategic moves and developments
8.5.5 SWOT analysis
8.6 Sanofi S.A.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Business performance
8.6.4 Key strategic moves and developments
8.6.5 SWOT analysis
8.7 Atrium Medical Corporation (Maquet Getinge Group)
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Business performance
8.7.4 SWOT analysis
8.8 Hemostasis LLC
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 SWOT analysis
8.9 Cryolife Inc.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Business performance
8.9.4 Key strategic moves and developments
8.9.5 SWOT analysis
8.10 Kuros Bioscience
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Key strategic moves and developments
8.10.4 SWOT analysis
